Fortis Healthcare Limited (FORTIS) announced signing agreements to provide healthcare services to a new 400+ bedded super specialty hospital in Delhi.
Alkem Laboratories Limited (ALKEM) launches NeuCeno (cenobamate) for partial-onset seizures, marking a significant advancement in epilepsy treatment.
Aurobindo Pharma Limited (NSE: AUROPHARMA) receives final approval from USFDA for Beclomethasone Dipropionate HFA Inhalation Aerosol.
Shilpa Medicare Limited (NSE: SHILPAMED) secures final approval for OERISTM, the world's first extended-release ondansetron injection, marking a significant.
Fabtech Technologies Limited (FABTECH) completes 14,000 sqm turnkey facility for Himalaya Wellness Company in UAE, showcasing engineering capabilities.
Alkem Laboratories Limited (ALKEM) launches Renocia Exo™, India’s first patented Ginsenoside exosome-based hair growth serum, addressing hair loss with regen.
Biocon Limited (BIOCON) secures a 10-year supply contract for Pertuzumab in Brazil, marking a significant milestone in advancing HER2-positive breast cancer.
Lupin Limited (LUPIN) secures U.S. FDA approval for Modafinil Tablets, expanding its generics portfolio with a bioequivalent to Provigil®.
Aster DM Quality Care Limited (ASTERDM) sees Dr. Moopen family increase stake by ~₹350 crore, raising their shareholding to 24.58%.
Cipla Limited (CIPLA) announces a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to Keytruda® in the US.